AstraZeneca erases billions after sobering reveal
Drug trials fail all the time. What is rare is a failure that costs a company tens of billions of dollars in a single afternoon. That is what happened to AstraZeneca (AZN) on July 9. One setback wiped out more market value than the stock had lost on any day in years. For investors, the

